Joshua Joo

Array ( [id] => 837019 [patent_doc_number] => 07393834 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-01 [patent_title] => 'LHRH-antagonists in the treatment of fertility disorders' [patent_app_type] => utility [patent_app_number] => 10/661780 [patent_app_country] => US [patent_app_date] => 2003-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2835 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/393/07393834.pdf [firstpage_image] =>[orig_patent_app_number] => 10661780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7468625 [patent_doc_number] => 20040053977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'Medicinal uses of hydrazones' [patent_app_type] => new [patent_app_number] => 10/661905 [patent_app_country] => US [patent_app_date] => 2003-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14349 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20040053977.pdf [firstpage_image] =>[orig_patent_app_number] => 10661905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7070192 [patent_doc_number] => 20050245577 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Drug for kidney failure containing oxaluric acid derivative' [patent_app_type] => utility [patent_app_number] => 10/526527 [patent_app_country] => US [patent_app_date] => 2003-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1812 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20050245577.pdf [firstpage_image] =>[orig_patent_app_number] => 10526527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7310887 [patent_doc_number] => 20040143015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Combination of organic compounds' [patent_app_type] => new [patent_app_number] => 10/471253 [patent_app_country] => US [patent_app_date] => 2003-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9451 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20040143015.pdf [firstpage_image] =>[orig_patent_app_number] => 10471253 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 860469 [patent_doc_number] => 07371729 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-13 [patent_title] => 'Boronic acid salts useful in parenteral formulations' [patent_app_type] => utility [patent_app_number] => 10/658971 [patent_app_country] => US [patent_app_date] => 2003-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 34592 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 173 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/371/07371729.pdf [firstpage_image] =>[orig_patent_app_number] => 10658971 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5777393 [patent_doc_number] => 20060106033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Pyrazolopyridines and methods of making and using the same' [patent_app_type] => utility [patent_app_number] => 10/526839 [patent_app_country] => US [patent_app_date] => 2003-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9870 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20060106033.pdf [firstpage_image] =>[orig_patent_app_number] => 10526839 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7474105 [patent_doc_number] => 20040122008 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Treatment of pain by inhibition of p38 MAP kinase' [patent_app_type] => new [patent_app_number] => 10/655745 [patent_app_country] => US [patent_app_date] => 2003-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 24734 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20040122008.pdf [firstpage_image] =>[orig_patent_app_number] => 10655745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7322580 [patent_doc_number] => 20040137078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Physiologically balanced, ionized, acidic solution and methodology for use in wound healing' [patent_app_type] => new [patent_app_number] => 10/655493 [patent_app_country] => US [patent_app_date] => 2003-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17939 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20040137078.pdf [firstpage_image] =>[orig_patent_app_number] => 10655493 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7169782 [patent_doc_number] => 20040077702 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'Treatment of nuerodegenerative diseases' [patent_app_type] => new [patent_app_number] => 10/653859 [patent_app_country] => US [patent_app_date] => 2003-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3839 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20040077702.pdf [firstpage_image] =>[orig_patent_app_number] => 10653859 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7469768 [patent_doc_number] => 20040102473 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Method of preventing or treating atherosclerosis or restenosis' [patent_app_type] => new [patent_app_number] => 10/651216 [patent_app_country] => US [patent_app_date] => 2003-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15779 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20040102473.pdf [firstpage_image] =>[orig_patent_app_number] => 10651216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7468884 [patent_doc_number] => 20040054005 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'Sodium channel blocker compositions and the use thereof' [patent_app_type] => new [patent_app_number] => 10/644783 [patent_app_country] => US [patent_app_date] => 2003-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9770 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20040054005.pdf [firstpage_image] =>[orig_patent_app_number] => 10644783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 570040 [patent_doc_number] => 07462638 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-09 [patent_title] => 'Use of IκB-kinase inhibitors in pain therapy' [patent_app_type] => utility [patent_app_number] => 10/642974 [patent_app_country] => US [patent_app_date] => 2003-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14971 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/462/07462638.pdf [firstpage_image] =>[orig_patent_app_number] => 10642974 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7330226 [patent_doc_number] => 20040254234 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Medicament for prevention and/or therapy of arterial wall disorder' [patent_app_type] => new [patent_app_number] => 10/643404 [patent_app_country] => US [patent_app_date] => 2003-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4916 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20040254234.pdf [firstpage_image] =>[orig_patent_app_number] => 10643404 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7169927 [patent_doc_number] => 20040077730 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'Medical treatment' [patent_app_type] => new [patent_app_number] => 10/641506 [patent_app_country] => US [patent_app_date] => 2003-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4552 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20040077730.pdf [firstpage_image] =>[orig_patent_app_number] => 10641506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 263804 [patent_doc_number] => 07569569 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-04 [patent_title] => 'Pyrrolo[2,3-d]pyrimidine compounds' [patent_app_type] => utility [patent_app_number] => 10/640079 [patent_app_country] => US [patent_app_date] => 2003-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12706 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/569/07569569.pdf [firstpage_image] =>[orig_patent_app_number] => 10640079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7380318 [patent_doc_number] => 20040081678 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-29 [patent_title] => 'Therapeutic process for the treatment of obesity and associated metabolic disorders' [patent_app_type] => new [patent_app_number] => 10/635841 [patent_app_country] => US [patent_app_date] => 2003-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4595 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20040081678.pdf [firstpage_image] =>[orig_patent_app_number] => 10635841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7674683 [patent_doc_number] => 20040127435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Uses for inhibitors of inosine monophosphate dehydrogenase' [patent_app_type] => new [patent_app_number] => 10/632711 [patent_app_country] => US [patent_app_date] => 2003-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 20129 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20040127435.pdf [firstpage_image] =>[orig_patent_app_number] => 10632711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7396058 [patent_doc_number] => 20040022827 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Remedy for hepatopathy' [patent_app_type] => new [patent_app_number] => 10/629838 [patent_app_country] => US [patent_app_date] => 2003-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4175 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20040022827.pdf [firstpage_image] =>[orig_patent_app_number] => 10629838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5748501 [patent_doc_number] => 20060111433 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-25 [patent_title] => 'Use of angelicin and of its structural analogues for the treatment of thalassemia' [patent_app_type] => utility [patent_app_number] => 10/522737 [patent_app_country] => US [patent_app_date] => 2003-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2132 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20060111433.pdf [firstpage_image] =>[orig_patent_app_number] => 10522737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7674675 [patent_doc_number] => 20040127443 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Novel PPAR ligands that do not cause fluid retention, edema or congestive heart failure' [patent_app_type] => new [patent_app_number] => 10/627372 [patent_app_country] => US [patent_app_date] => 2003-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21958 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20040127443.pdf [firstpage_image] =>[orig_patent_app_number] => 10627372 [rel_patent_id] =>[rel_patent_doc_number] =>)